These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11081399)

  • 1. Etanercept in graft-versus-host disease.
    Andolina M; Rabusin M; Maximova N; Di Leo G
    Bone Marrow Transplant; 2000 Oct; 26(8):929. PubMed ID: 11081399
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors.
    Thin L; Macquillan G; Adams L; Garas G; Seow C; Cannell P; Augustson B; Mitchell A; Delriveire L; Jeffrey G
    Liver Transpl; 2009 Apr; 15(4):421-6. PubMed ID: 19326415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot trial on the use of etanercept and methylprednisolone as primary treatment for acute graft-versus-host disease.
    Uberti JP; Ayash L; Ratanatharathorn V; Silver S; Reynolds C; Becker M; Reddy P; Cooke KR; Yanik G; Whitfield J; Jones D; Hutchinson R; Braun T; Ferrara JL; Levine JE
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):680-7. PubMed ID: 16125638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of correlation between serum levels and receptor expression of TNF alpha and graft versus host disease following allogeneic bone marrow transplantation.
    Robinet E; Pico JL; Ibrahim A; Ostronoff M; Zambon E; Zohar M; Truneh A; Gay F; Hayat M; Chouaib S
    Bone Marrow Transplant; 1991; 7 Suppl 2():148. PubMed ID: 1652325
    [No Abstract]   [Full Text] [Related]  

  • 5. TNF-alpha targeted therapeutic approaches in patients with hematologic malignancies.
    Tsimberidou AM; Giles FJ
    Expert Rev Anticancer Ther; 2002 Jun; 2(3):277-86. PubMed ID: 12113051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal anti TNF alpha antibody in the treatment of acute GvHD refractory both to corticosteroids and anti IL-2 R antibody.
    Hervé P; Racadot E; Wijdenes J; Flesch M; Tiberghien P; Bordigoni P; Holler E; Powles M; Bourdeau M; Wilmer E
    Bone Marrow Transplant; 1991; 7 Suppl 2():149. PubMed ID: 1878688
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacteremias and invasive fungal diseases in children receiving etanercept for steroid-resistant acute GVHD.
    Faraci M; Lanino E; Morreale G; Giardino S; Fossati M; Moroni C; Caviglia I; Castagnola E
    Bone Marrow Transplant; 2011 Jan; 46(1):159-60. PubMed ID: 20383214
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha associated with chronic graft-versus-host disease in bone marrow transplantation recipients.
    Fujii Y; Kaku K; Kaneko T
    Bone Marrow Transplant; 1992 Aug; 10(2):194-5. PubMed ID: 1525611
    [No Abstract]   [Full Text] [Related]  

  • 10. Etanercept for the treatment of hidradenitis suppurativa.
    Sotiriou E; Apalla Z; Ioannidos D
    Acta Derm Venereol; 2009; 89(1):82-3. PubMed ID: 19197548
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of etanercept and other tumor necrosis factor-alpha blockers in infertility: it's time to get serious.
    Wallace DJ
    J Rheumatol; 2003 Sep; 30(9):1897-9. PubMed ID: 12966586
    [No Abstract]   [Full Text] [Related]  

  • 12. Adolescent plaque psoriasis: our experience using etanercept.
    Ruiz-Villaverde R; Sánchez-Cano D; Abalos-Medina G
    J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):976-7. PubMed ID: 19207668
    [No Abstract]   [Full Text] [Related]  

  • 13. Pemphigus foliaceus treated with etanercept.
    Gubinelli E; Bergamo F; Didona B; Annessi G; Atzori F; Raskovic D
    J Am Acad Dermatol; 2006 Dec; 55(6):1107-8. PubMed ID: 17110226
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis.
    Tynjälä P; Vähäsalo P; Honkanen V; Lahdenne P
    Ann Rheum Dis; 2009 Apr; 68(4):552-7. PubMed ID: 18467515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of juvenile pityriasis rubra pilaris with etanercept.
    Cox V; Lesesky EB; Garcia BD; O'Grady TC
    J Am Acad Dermatol; 2008 Nov; 59(5 Suppl):S113-4. PubMed ID: 19119116
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept).
    Pastor N; Betlloch I; Pascual JC; Blanes M; Bañuls J; Silvestre JF
    Clin Exp Dermatol; 2006 Jan; 31(1):152-3. PubMed ID: 16309525
    [No Abstract]   [Full Text] [Related]  

  • 17. Etanercept is effective in patients with rheumatoid arthritis with no response to infliximab therapy.
    Gómez-Puerta JA; Sanmartí R; Rodríguez-Cros JR; Cañete JD
    Ann Rheum Dis; 2004 Jul; 63(7):896. PubMed ID: 15194598
    [No Abstract]   [Full Text] [Related]  

  • 18. Etanercept in a 7-year-old boy with severe and recalcitrant psoriasis.
    Safa G; Loppin M; Bousser AM; Barbarot S
    J Am Acad Dermatol; 2007 Feb; 56(2 Suppl):S19-20. PubMed ID: 17097376
    [No Abstract]   [Full Text] [Related]  

  • 19. Taiwan experience with etanercept in juvenile rheumatoid arthritis.
    Lai JH
    J Microbiol Immunol Infect; 2005 Dec; 38(6):451-4. PubMed ID: 16341348
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept.
    Kekow J; Welte T; Kellner U; Pap T
    Arthritis Rheum; 2002 Mar; 46(3):843-4. PubMed ID: 11920425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.